Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
ASP2535
ASP2535 from MedChemExpress
Be the first to write a review!
Citations:
(2)
Supplier Page
Supplier Page from
MedChemExpress for
ASP2535
Get Pricing
Description
ASP2535 is a potent, orally bioavailable, selective, brain permeable and centrally-active
glycine transporter-1 (GlyT1)
inhibitor. ASP2535 can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
ASP2535
Company
MedChemExpress
Price
$484.00
Supplier Page
View Company Product Page
Catalog Number
HY-110176
Quantity
10 mM * 1 mL
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity
99.44%
Type
Chemical
Molecular Weight
382.42
Formula
C₂₂H₁₈N₆O
Research Area
Neurological Disease
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (2)
(1)
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease
European journal of pharmacology
June 15, 2012
Harada K, Nakato K, Yarimizu J, Yamazaki M, Morita M, Takahashi S, Aota M, Saita K, Doihara H, Sato Y,
et al
.
(2)
Chemotherapy in gynecologic cancer
Current opinion in oncology
September 1, 1998
Sabbatini P, Aghajanian C, Spriggs D.
<<
<
>
>>
Reviews
Be the First to Write a Review!
ASP2535 from MedChemExpress
Supplier Page
View Company Product Page
$484.00
Product Specs
Company Info
Citations
Reviews
Back To Top